Lithium Therapy Improves Neurological Function in a Mouse Model of Spinocerebellar Ataxia Type 1
Author Information
Author(s): Watase Kei, Gatchel Jennifer R, Sun Yaling, Emamian Effat, Atkinson Richard, Richman Ronald, Mizusawa Hidehiro, Orr Harry T, Shaw Chad, Zoghbi Huda Y
Primary Institution: Baylor College of Medicine
Hypothesis
Can lithium treatment improve neurological function and cognitive deficits in a mouse model of spinocerebellar ataxia type 1?
Conclusion
Lithium treatment improves motor coordination and cognitive function in a mouse model of spinocerebellar ataxia type 1, even when started after the onset of symptoms.
Supporting Evidence
- Lithium treatment improved motor coordination in Sca1154Q/2Q mice.
- Behavioral tests showed enhanced learning and memory in lithium-treated mice.
- Lithium restored levels of a key gene associated with SCA1 pathology.
- Improvements were observed even when treatment started after symptoms appeared.
Takeaway
Giving lithium to mice with a brain disease helped them move better and think more clearly, even if they started taking it after they got sick.
Methodology
Mice were fed a diet with or without lithium carbonate, and their motor and cognitive functions were assessed through various behavioral tests.
Potential Biases
The study was conducted by researchers affiliated with institutions that may have a vested interest in the outcomes.
Limitations
The study did not assess the long-term effects of lithium treatment on lifespan or potential side effects in the context of cerebellar dysfunction.
Participant Demographics
The study used Sca1154Q/2Q mice, a model for spinocerebellar ataxia type 1, and their wild-type littermates.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website